Join Growin Stock Community!

宏碁智醫6857.TW Overview

TW StockBiotech. & Medical
(No presentation for 6857)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

宏碁智醫（6857）Overall Performance

宏碁智醫（6857）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

宏碁智醫（6857） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

宏碁智醫（6857）Key Information

宏碁智醫（6857）Profile

Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. It offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan.

宏碁智醫（6857）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-3.94
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
15.24
PB Ratio
8.53
Price-to-FCF
70.43
METRIC
VALUE
vs. INDUSTRY
Gross Margin
58.61%
Net Margin
-59.79%
Revenue Growth (YoY)
290.22%
Profit Growth (YoY)
355.29%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-3.94
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
15.24
PB Ratio
8.53
Price-to-FCF
70.43
Gross Margin
58.61%
Net Margin
-59.79%
Revenue Growth (YoY)
290.22%
Profit Growth (YoY)
355.29%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
default symbol

6857

宏碁智醫

100.50D

0.50%

(0.00)

  • When is 6857's latest earnings report released?

    The most recent financial report for 宏碁智醫 (6857) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6857's short-term business performance and financial health. For the latest updates on 6857's earnings releases, visit this page regularly.

  • What is the operating profit of 6857?

    According to the latest financial report, 宏碁智醫 (6857) reported an Operating Profit of -16.6M with an Operating Margin of -55.11% this period, representing a decline of 21.39% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 6857's revenue growth?

    In the latest financial report, 宏碁智醫 (6857) announced revenue of 30.12M, with a Year-Over-Year growth rate of 19.63%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 6857 have?

    At the end of the period, 宏碁智醫 (6857) held Total Cash and Cash Equivalents of 182.27M, accounting for 0.87 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 6857 go with three margins increasing?

    In the latest report, 宏碁智醫 (6857) did not achieve the “three margins increasing” benchmark, with a gross margin of 60.62%%, operating margin of -55.11%%, and net margin of -50.28%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6857's profit trajectory and future growth potential.

  • Is 6857's EPS continuing to grow?

    According to the past four quarterly reports, 宏碁智醫 (6857)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.99. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 6857?

    宏碁智醫 (6857)'s Free Cash Flow (FCF) for the period is 719K, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 130.38% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.